March 3, 2007
Pharmacosmos participates in the World Congress of Nephrology (WCN) 2007. The congress is held in Rio de Janeiro, Brazil, during the period April 20-25, 2007.
For additional information about the World Congress of Nephrology 2007, please visit the World Congress of Nephrology Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.